Our top pick for
Beginners
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.
How to buy Illumina stock | $270.13
Own Illumina stock in just a few minutes.
Illumina, Inc is a diagnostics & research business based in the US. Illumina shares (ILMN) are listed on the NASDAQ and all prices are listed in US Dollars. Illumina employs 7,700 staff and has a trailing 12-month revenue of around USD$3.4 billion.
How to buy shares in Illumina
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Illumina Find the stock by name or ticker symbol: ILMN. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Illumina reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of USD$270.13, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Illumina, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Illumina. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- ILMN shares summary
- Compare share dealing platforms
- Is ILMN stock a buy or sell?
- Stock performance over time
- Can I short ILMN shares?
- Is ILMN suitable for ethical investing?
- Are ILMN shares over-valued?
- Illumina's financials
- How volatile are ILMN shares?
- Does Illumina pay a dividend?
- Have ILMN shares ever split?
- Other common questions
How has coronavirus impacted Illumina's share price?
Since the stock market crash in March caused by coronavirus, Illumina's share price has had significant negative movement.
Its last market close was USD$270.13, which is 8.72% down on its pre-crash value of USD$295.94 and 37.28% up on the lowest point reached during the March crash when the shares fell as low as USD$196.78.
If you had bought USD$1,000 worth of Illumina shares at the start of February 2020, those shares would have been worth USD$810.76 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$921.14.
Illumina share price
Use our graph to track the performance of ILMN stocks over time.Illumina shares at a glance
Information last updated 2020-09-21.
| Latest market close | USD$270.13 |
|---|---|
| 52-week range | USD$196.78 - USD$404.2 |
| 50-day moving average | USD$352.385 |
| 200-day moving average | USD$332.7401 |
| Wall St. target price | USD$351.33 |
| PE ratio | 63.8158 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$4.676 |
Compare trading platforms
Compare special offers, low fees and a wide range of types of investments among top trading platforms.The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Illumina stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Illumina price performance over time
Historical closes compared with the last close of $270.13
| 1 week (2020-09-11) | N/A |
|---|---|
| 1 month (2020-08-18) | N/A |
| 3 months (2020-06-22) | -25.06% |
| 6 months (2020-03-20) | 11.62% |
| 1 year (2019-09-18) | N/A |
|---|---|
| 2 years (2018-09-18) | N/A |
| 3 years (2017-09-18) | N/A |
| 5 years (2015-09-18) | N/A |
Is Illumina under- or over-valued?
Valuing Illumina stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Illumina's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Illumina's P/E ratio
Illumina's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 64x. In other words, Illumina shares trade at around 64x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Illumina's PEG ratio
Illumina's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.308. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Illumina's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Illumina's EBITDA
Illumina's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$1.2 billion.
The EBITDA is a measure of a Illumina's overall financial performance and is widely used to measure a its profitability.
Illumina financials
| Revenue TTM | USD$3.4 billion |
|---|---|
| Operating margin TTM | 29.69% |
| Gross profit TTM | USD$2.5 billion |
| Return on assets TTM | 8.75% |
| Return on equity TTM | 15.58% |
| Profit margin | 20.68% |
| Book value | $31.253 |
| Market capitalisation | USD$40.5 billion |
TTM: trailing 12 months
Shorting Illumina shares
There are currently 3.9 million Illumina shares held short by investors – that's known as Illumina's "short interest". This figure is 10.5% up from 3.5 million last month.
There are a few different ways that this level of interest in shorting Illumina shares can be evaluated.
Illumina's "short interest ratio" (SIR)
Illumina's "short interest ratio" (SIR) is the quantity of Illumina shares currently shorted divided by the average quantity of Illumina shares traded daily (recently around 920794.58823529). Illumina's SIR currently stands at 4.25. In other words for every 100,000 Illumina shares traded daily on the market, roughly 4250 shares are currently held short.
However Illumina's short interest can also be evaluated against the total number of Illumina shares, or, against the total number of tradable Illumina shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Illumina's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Illumina shares in existence, roughly 30 shares are currently held short) or 0.0306% of the tradable shares (for every 100,000 tradable Illumina shares, roughly 31 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Illumina.
Find out more about how you can short Illumina stock.
Illumina's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Illumina.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Illumina's total ESG risk score
Total ESG risk: 10.16
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Illumina's overall score of 10.16 (as at 08/01/2020) is excellent – landing it in it in the 3rd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Illumina is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Illumina's environmental score
Environmental score: 2.22/100
Illumina's environmental score of 2.22 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Illumina is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Illumina's social score
Social score: 2.6/100
Illumina's social score of 2.6 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Illumina is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Illumina's governance score
Governance score: 6.34/100
Illumina's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that Illumina is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Illumina's controversy score
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Illumina scored a 1 out of 5 for controversy – the highest score possible, reflecting that Illumina has managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
Illumina, Inc was last rated for ESG on: 2020-08-01.
| Total ESG score | 10.16 |
|---|---|
| Total ESG percentile | 2.66 |
| Environmental score | 2.22 |
| Environmental score percentile | 2 |
| Social score | 2.6 |
| Social score percentile | 2 |
| Governance score | 6.34 |
| Governance score percentile | 2 |
| Level of controversy | 1 |
Illumina share dividends
We're not expecting Illumina to pay a dividend over the next 12 months.
Have Illumina's shares ever split?
Illumina's shares were split on a 2:1 basis on 23 September 2008. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Illumina shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Illumina shares which in turn could have impacted Illumina's share price.
Illumina share price volatility
Over the last 12 months, Illumina's shares have ranged in value from as little as $196.78 up to $404.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Illumina's is 0.8757. This would suggest that Illumina's shares are less volatile than average (for this exchange).
Illumina overview
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in certain markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Frequently asked questions
Ask an Expert